Morgan Stanley’s NeOnc Technologies NTHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.9K Sell
15,647
-36,275
-70% -$181K ﹤0.01% 6380
2026
Q1
$364K Buy
51,922
+43,718
+533% +$397K ﹤0.01% 5621
2025
Q4
$67.8K Buy
+8,204
New +$76.9K ﹤0.01% 6338

Other funds holding NTHI

Morgan Stanley's NTHI Position: Q2 2026 in Review

Morgan Stanley reduced its NeOnc Technologies (NTHI) stake by 70% in Q2 2026, selling an estimated $181K and leaving 15,647 shares worth $70.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6380.

Morgan Stanley first reported a position in NTHI in Q4 2025 and has held it in 3 quarters since. The position peaked at $364K in Q1 2026. 21 funds tracked by Wall St. Rank hold NTHI as of Q2 2026.

  • Morgan Stanley held 15,647 shares of NeOnc Technologies worth $70.9K as of Q2 2026.
  • Morgan Stanley sold 36,275 NeOnc Technologies shares in Q2 2026, an estimated $181K.
  • NeOnc Technologies made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6380 holding.
  • Morgan Stanley first reported a position in NeOnc Technologies in Q4 2025 and has held it in 3 quarters since.
  • Morgan Stanley's NeOnc Technologies position peaked at $364K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held NeOnc Technologies as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.